0002009739-24-000001.txt : 20240729 0002009739-24-000001.hdr.sgml : 20240729 20240729104021 ACCESSION NUMBER: 0002009739-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240729 DATE AS OF CHANGE: 20240729 EFFECTIVENESS DATE: 20240729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avant Sciences, Inc. CENTRAL INDEX KEY: 0002009739 ORGANIZATION NAME: IRS NUMBER: 932573266 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-519935 FILM NUMBER: 241149728 BUSINESS ADDRESS: STREET 1: 201 E. 86TH STREET STREET 2: STE 7D CITY: NEW YORK STATE: NY ZIP: 10028 BUSINESS PHONE: 650-387-1268 MAIL ADDRESS: STREET 1: 201 E. 86TH STREET STREET 2: STE 7D CITY: NEW YORK STATE: NY ZIP: 10028 D 1 primary_doc.xml X0708 D LIVE 0002009739 Avant Sciences, Inc. 201 E. 86TH STREET STE 7D NEW YORK NY NEW YORK 10028 650-387-1268 DELAWARE None None Corporation true 2023 Avnish Deobhakta c/o Avant Sciences, Inc. 201 E. 86th Street, Suite 7D New York NY NEW YORK 10028 Executive Officer Director Paul Lee c/o Avant Sciences, Inc. 201 E 86th Street, Suite 7D New York NY NEW YORK 10028 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2024-01-12 false true false 25000 300000 175000 125000 The Issuer in its discretion may increase the total offering amount by another $300,000. false 5 0 0 0 false Avant Sciences, Inc. /s/ Avnish Deobhakta President 2024-07-26